The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
| Autor: | Bramlage, Peter1 peter.bramlage@ippmed.de, Schmieder, Roland E.2, Gitt, Anselm K.3,4, Baumgart, Peter5, Mahfoud, Felix6, Buhck, Hartmut7, Ouarrak, Taoufik3, Ehmen, Martina8, Potthoff, Sebastian A.9, EARLY Registry Group (CORPORATE AUTHOR) |
|---|---|
| Zdroj: | Trials. 12/19/2015, Vol. 16 Issue 1, p1-9. 9p. 1 Diagram, 4 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|